ADAM9 and Alzheimer disease: Consistent with our AD-PCR-Array data, we observed significant increase in the levels of APP (Fig. 2F) and its processing enzyme BACE1 (Fig. 3D), while the levels of ADAM9 remained unaltered in MS9II cells as compared with MS cells (Fig. 3C).